Acquisition Announced

Ipsen acquisition of Memo Therapeutics

€200m consideration

Announced 7 Jul 2026

Advisers

Ipsen

Acquirer

Not disclosed

Target
Memo Therapeutics
Acquirer
Ipsen
Target based in
Switzerland
Buyer based in
France
Sector
Biotech

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.